 WESTLAKE VILLAGE, Calif., June 25, 2021 PRNewswire -- MannKind Corporation Nasdaq: MNKD, which focuses on the development of innovative medicines for patients with endocrine and orphan lung diseases, will present two posters at the American Diabetes Associations virtual 81st Scientific Sessions, June 25-29. 